Product Images Darifenacin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Darifenacin NDC 33342-277 by Macleods Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure - darifenacin structure
darifenacin tab 15mg 30s container
Each extended-release tablet contains 15 mg of darifenacin hydrobromide. Darifenacin is used for the treatment of urinary incontinence. The usual dosage is one tablet daily. The tablets should be stored at a temperature between 20-25°C (68-77°F) and protected from light. This drug should be kept out of reach of children. The product is manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. and comes in a package of 30 tablets. Further information can be found in the enclosed information leaflet with the drug product.*
darifenacin tab 15mg 90s container
This is a description of a medication called Darifenacin that comes in the form of extended-release tablets. The box contains 90 tablets, and each tablet contains 17.846 mg of darifenacin hydrobromide which provides less than 15 mg of darifenacin. The recommended dosage is one tablet daily, and the medication should be stored between 20 to 25°C (68 to 77°F) with permitted excursions of 15 to 30°C (59 to 86°F). The manufacturer is Macleods Pharma USA, Inc. and it is manufactured by Macleods Pharmaceuticals Ltd. The code number is HP/152/07. A patient information leaflet should be included with the medication.*
darifenacin tab 7 5mg 30s container
This is a medication information leaflet for Darifenacin extended-release tablets containing 8.923mg of darifenacin hydrobromide to provide 7.5mg of darifenacin. The usual recommended dosage is one tablet per day. The tablets are stored at 20-25°C. The leaflet includes the drug's code and manufacturing information.*
darifenacin tab 7 5mg 90s container
This is a drug product named "Darifenacin" manufactured by Macleods Pharma USA containing tablets of 7.5mg of Darifenacin hydrobromide. Each extended-release tablet contains 8.923 mg of Darifenacin. The usual dosage is one tablet daily, and it should be stored at 20° to 25°C (68° to 77°F). The drug product should be protected from light and kept out of the reach of children. There is also a note for pharmacists to dispense the patient information leaflet with the product. The NDC number for this drug is 33342-276-10. OPZ AREA is mentioned as 40 X 20.5mm. The drug product is manufactured for Macleods Pharma USA, Inc. The manufacturing company is Macleods Pharmaceuticals Ltd. in Baddi, Himachal Pradesh, INDIA.*
figure-1 - darifenacin tab figure 1
figure-2a - darifenacin tab figure 2a
figure-2b - darifenacin tab figure 2b
figure-2c - darifenacin tab figure 2c
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.